Iddo Nadav Weiner

Company: BiomX

Job title: VP Research

Seminars:

BX004-A: a nebulized anti-Pseudomonas aeruginosa phage cocktail for treatment of cystic fibrosis patients 8:30 am

Phage therapy is a promising technology for combatting lifethreatening antibiotic-resistant bacteria In BiomX we develop holistic phage technologies – from target identification through phage discovery and cocktail development, all the way to regulatory submissions and clinical trial operations In our cystic fibrosis project, we applied many of these capabilities, thus developing an efficient phage cocktail…Read more

day: Day Two